#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic sclerosis pulmonary Skin angiosarcoma Chronic myeloid leukaemia (in remission) Carcinoid tumour Wiskott-Aldrich syndrome Factor VIII deficiency Hereditary spastic paraplegia Tuberous sclerosis complex Raynaud's phenomenon Gastrointestinal disorder Lymphangiosarcoma Infective uveitis Non-Hodgkin's lymphoma refractory Henoch-Schonlein purpura nephritis Medullary thyroid cancer More trials…

    Learn about Rare Diseases

    Osteosarcoma recurrent – Treatment Amyotrophic lateral sclerosis – Treatment Carcinoid syndrome – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Bronchopulmonary dysplasia – Diagnostics Primary hyperoxaluria – Life with Disease Pituitary-dependent Cushing’s syndrome – Life with Disease Lysosomal storage disorder – Treatment Hereditary angioedema Pelizaeus-Merzbacher disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mirodenafil Dihydrochloride HUMAN FIBROBLASTS Human Plasma Protein Tiaprofenic Acid Nadunolimab Vidutolimod Tetracycline Hydrochloride GSKVX000000048111 Fludarabine Phosphate Granisetron NIZUBAGLUSTAT Valproic Acid Tramazoline Hydrochloride Emibetuzumab Follitropin Beta Asparaginase Alxn2220 Atidarsagene Autotemcel Indacaterol Acetate Lactulose More therapies…

    Learn about Your Condition

    Urinary tract infection Procedural haemorrhage Acute cardiac event Malignant melanoma of eyelid Nasal sinus cancer Pneumonia chlamydial Prostate cancer recurrent Neuroblastoma Neoplasm Penile cancer Pulmonary tuberculosis Retinal neovascularisation Metastases to biliary tract Salivary gland cancer Post-traumatic stress disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Diabetic retinal oedema
    Investigated Drugs:
    • Eye103
    • Ranibizumab
    • Fluorescein Sodium
    Austria Croatia Czechia France Germany Hungary +6

  • Study on the Effects of Povetacicept for Adults with IgA Nephropathy

    Not recruiting

    3 1
    Investigated Diseases:
    • Nephropathy
    Investigated Drugs:
    • Povetacicept
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Ublituximab
    Croatia Poland

  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Bulgaria France Hungary Italy The Netherlands Poland +2

  • Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Skin cancer
    • Basal cell carcinoma
    Investigated Drugs:
    • Balstilimab
    Poland

  • Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Empagliflozin
    Poland
Previous Page
1 … 1,656 1,657 1,658 1,659 1,660 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!